Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1078	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1086	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1115	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1132	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1151	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1156	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1159	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1240	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1240	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1310	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1359	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1473	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1484	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1534	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1573	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1589	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1608	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1701	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1727	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1761	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1793	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1822	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1833	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1846	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1866	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	1993	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2038	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2070	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2075	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2089	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2119	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2157	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2180	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2207	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2246	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2259	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2320	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2384	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2384	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2425	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2513	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2521	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2571	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2576	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2601	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2610	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2620	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	2744	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3070	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3104	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3269	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3271	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3313	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3396	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3409	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	3634	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	4113	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	4128	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	4354	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	5648	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-	6054	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+	1028	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+	1679	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+	3016	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y